menu search

THKKF / Think Research closes initial advance of $10 million from Beedie Investments under non-revolving term convertible loan facility

Think Research closes initial advance of $10 million from Beedie Investments under non-revolving term convertible loan facility
Think Research Corp said it has closed an initial advance of $10 million from Beedie Investments Ltd (Beedie Capital) under the company's non-revolving term convertible loan facility of up to the principal amount of $25 million.  Under the terms of the credit agreement between Think and Beedie Capital dated April 22, 2022, the firm may use the proceeds of the initial advance to fund future acquisitions, organic growth investments, and for general working capital purposes. Read More
Posted: May 11 2022, 06:46
Author Name: Proactive Investors
Views: 111531

THKKF News  

Think Research posts 82% jump in 3Q revenue on optimized operations and streamlined costs

By Proactive Investors
November 28, 2022

Think Research posts 82% jump in 3Q revenue on optimized operations and streamlined costs

Think Research Corporation (TSX-V:THNK, OTCQB:THKKF) has posted its financial results for the three months and nine months ended September 30, showing more_horizontal

Think Research says Beedie Investments approves second advance from current credit agreement; gives positive outlook

By Proactive Investors
November 22, 2022

Think Research says Beedie Investments approves second advance from current credit agreement; gives positive outlook

Think Research Corporation (TSX-V:THNK, OTCQB:THKKF) says Beedie Investments Ltd has continued to show its support of the company with a second advanc more_horizontal

Think Research reports 80% year-over-year surge in 2Q revenue

By Proactive Investors
August 29, 2022

Think Research reports 80% year-over-year surge in 2Q revenue

Think Research Corporation (TSX-V:THNK, OTCQB:THKKF) has reported second-quarter results, posting a significant year-over-year revenue bump and issuin more_horizontal

Think Research signs contract to provide Care Pathways nursing content to St. George's University Hospitals

By Proactive Investors
July 6, 2022

Think Research signs contract to provide Care Pathways nursing content to St. George's University Hospitals

Think Research Corporation (TSX-V:THNK, OTCQB:THKKF) said it has signed a contract to provide Care Pathways nursing content to St. George's University more_horizontal

Think Research Corporation wins contract from major US pharmacy to deliver business intelligence and support solutions

By Proactive Investors
June 28, 2022

Think Research Corporation wins contract from major US pharmacy to deliver business intelligence and support solutions

Think Research Corporation (TSX-V:THNK, OTCQB:THKKF) said it has been contracted by a major US-based pharmacy to deliver business intelligence and sup more_horizontal

Canaccord Genuity repeats 'Speculative Buy' rating and $2.00 price target on Think Research after its Q1 results beat expectations

By Proactive Investors
June 1, 2022

Canaccord Genuity repeats 'Speculative Buy' rating and $2.00 price target on Think Research after its Q1 results beat expectations

Canaccord Genuity (TSX:CF, LSE:CF) analysts have repeated a 'Speculative Buy' rating and $2.00 price target on Think Research Corporation (TSX-V:THNK) more_horizontal

Think Research reports record first-quarter revenue as software and data solutions business continues to grow

By Proactive Investors
May 30, 2022

Think Research reports record first-quarter revenue as software and data solutions business continues to grow

Think Research Corporation (TSX-V:THNK) has reported record sales for the first quarter to March 31, 2022, driven by continued growth in the company's more_horizontal

Think Research enters $4.1M content and learning management agreement with global pharmaceutical company

By Proactive Investors
May 19, 2022

Think Research enters $4.1M content and learning management agreement with global pharmaceutical company

Think Research Corporation (TSX-V:THNK) has announced that its MDBriefcase Group Inc subsidiary has been chosen by a global pharmaceutical company to more_horizontal


Search within

Pages Search Results: